美国心脏协会指南解读系列——《人工智能在心血管疾病中的应用科学声明》解读

Interpretation of the Use of Artificial Intelligence in Improving Outcomes in Heart Disease:a Scientific Statement from the American Heart Association

人工智能(AI)是改善卫生保健服务的新兴技术。在全球政府机构和学术部门的共同推进下,大量研究论证AI可以改进心血管疾病的诊断、治疗和预防,但其发展和应用仍存在一些限制,尚未在广泛范围内服务临床。基于此,美国心脏协会(AHA)于2024-04-02在Circulation发表了《人工智能在心血管疾病中的应用科学声明》(以下简称声明)。该声明综述了AI在心血管疾病诊断、分类和治疗中的研究进展,提出了AI应用中存在的问题以及潜在解决方案,并且构建了未来AI在心血管领域应用的框架。本文旨在对该声明进行解读,为我国AI在心血管疾病的应用和研究提供建议和方向。

Artificial Intelligence(AI)is an emerging technology to improve healthcare services.With the joint promotion of government agencies and academic departments around the world,a large number of studies have demonstrated that AI can improve the diagnosis,treatment and prevention of cardiovascular disease.However,there are still some limitations in its development and application,and it has not yet been widely used in clinical practice.Based on this,the American Heart Association(AHA)published the Use of Artificial Intelligence in Improving Outcomes in Heart Disease:a Scientific Statement from the American Heart Association in Circulation on April 2,2024.This statement reviews the research progress of AI in the diagnosis,classification and treatment of cardiovascular disease,puts forward the existing problems and potential solutions,and builds a framework for the future application of AI in the cardiovascular disease.This article aims to interpret the statement for providing advice and direction for the application and research of AI in cardiovascular disease in China.